{"id":"https://openalex.org/W2162969728","doi":"https://doi.org/10.1155/2013/739574","title":"Molecular Dynamics Simulation of VEGFR2 with Sorafenib and Other Urea-Substituted Aryloxy Compounds","display_name":"Molecular Dynamics Simulation of VEGFR2 with Sorafenib and Other Urea-Substituted Aryloxy Compounds","publication_year":2013,"publication_date":"2013-12-04","ids":{"openalex":"https://openalex.org/W2162969728","doi":"https://doi.org/10.1155/2013/739574","mag":"2162969728"},"language":"en","primary_location":{"id":"doi:10.1155/2013/739574","doi":"https://doi.org/10.1155/2013/739574","is_oa":true,"landing_page_url":"https://doi.org/10.1155/2013/739574","pdf_url":"https://downloads.hindawi.com/archive/2013/739574.pdf","source":{"id":"https://openalex.org/S4210188867","display_name":"Journal of Theoretical Chemistry","issn_l":"2314-6184","issn":["2314-6184","2356-7686"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310319869","host_organization_name":"Hindawi Publishing Corporation","host_organization_lineage":["https://openalex.org/P4310319869","https://openalex.org/P4310320595"],"host_organization_lineage_names":["Hindawi Publishing Corporation","Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Theoretical Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://downloads.hindawi.com/archive/2013/739574.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062865827","display_name":"Fancui Meng","orcid":"https://orcid.org/0000-0002-5064-0618","observed_orcids":["https://orcid.org/0000-0002-5064-0618"]},"institutions":[{"id":"https://openalex.org/I4210105139","display_name":"Tianjin Institute of Pharmaceutical Research (China)","ror":"https://ror.org/01g9y2x13","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210105139"]},{"id":"https://openalex.org/I4391767783","display_name":"State Key Laboratory of Pharmacokinetics and Drug Delivery Technology","ror":"https://ror.org/04g1mec21","country_code":"CN","type":"facility","lineage":["https://openalex.org/I4210105139","https://openalex.org/I4391767783"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Fancui Meng","raw_affiliation_strings":["State Key Laboratory of Drug Delivery Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China","Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China"],"raw_orcid":"https://orcid.org/0000-0002-5064-0618","affiliations":[{"raw_affiliation_string":"State Key Laboratory of Drug Delivery Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China","institution_ids":["https://openalex.org/I4210105139","https://openalex.org/I4391767783"]},{"raw_affiliation_string":"Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China","institution_ids":["https://openalex.org/I4210105139"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5062865827"],"corresponding_institution_ids":["https://openalex.org/I4210105139","https://openalex.org/I4391767783"],"apc_list":null,"apc_paid":null,"fwci":0.1691,"has_fulltext":true,"cited_by_count":23,"citation_normalized_percentile":{"value":0.40542373,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"2013","issue":null,"first_page":"1","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11908","display_name":"Protein Interaction Studies and Fluorescence Analysis","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10044","display_name":"Protein Structure and Dynamics","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vegfr2","display_name":"VEGFR2","score":0.996999979019165},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":1.0},{"id":"https://openalex.org/keywords/vegfr-2-inhibitors","display_name":"VEGFR-2 inhibitors","score":0.800000011920929},{"id":"https://openalex.org/keywords/protein-ligand-binding","display_name":"protein-ligand binding","score":0.7639999985694885},{"id":"https://openalex.org/keywords/hydrogen-bonding","display_name":"hydrogen bonding","score":0.8830000162124634},{"id":"https://openalex.org/keywords/binding-mode","display_name":"binding mode","score":0.3610000014305115},{"id":"https://openalex.org/keywords/drug-design","display_name":"drug design","score":0.33399999141693115}],"concepts":[{"id":"https://openalex.org/C59593255","wikidata":"https://www.wikidata.org/wiki/Q901663","display_name":"Molecular dynamics","level":2,"score":0.8809946179389954},{"id":"https://openalex.org/C112887158","wikidata":"https://www.wikidata.org/wiki/Q169324","display_name":"Hydrogen bond","level":3,"score":0.8511554002761841},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.7503470182418823},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.6302727460861206},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.578911304473877},{"id":"https://openalex.org/C2780365088","wikidata":"https://www.wikidata.org/wiki/Q48318","display_name":"Urea","level":2,"score":0.5418162941932678},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.4620816707611084},{"id":"https://openalex.org/C32909587","wikidata":"https://www.wikidata.org/wiki/Q11369","display_name":"Molecule","level":2,"score":0.3822961449623108},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3432022035121918},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3349613547325134},{"id":"https://openalex.org/C147597530","wikidata":"https://www.wikidata.org/wiki/Q369472","display_name":"Computational chemistry","level":1,"score":0.29534822702407837},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.16676709055900574},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.08591499924659729},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0673602819442749},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1155/2013/739574","doi":"https://doi.org/10.1155/2013/739574","is_oa":true,"landing_page_url":"https://doi.org/10.1155/2013/739574","pdf_url":"https://downloads.hindawi.com/archive/2013/739574.pdf","source":{"id":"https://openalex.org/S4210188867","display_name":"Journal of Theoretical Chemistry","issn_l":"2314-6184","issn":["2314-6184","2356-7686"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310319869","host_organization_name":"Hindawi Publishing Corporation","host_organization_lineage":["https://openalex.org/P4310319869","https://openalex.org/P4310320595"],"host_organization_lineage_names":["Hindawi Publishing Corporation","Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Theoretical Chemistry","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1155/2013/739574","doi":"https://doi.org/10.1155/2013/739574","is_oa":true,"landing_page_url":"https://doi.org/10.1155/2013/739574","pdf_url":"https://downloads.hindawi.com/archive/2013/739574.pdf","source":{"id":"https://openalex.org/S4210188867","display_name":"Journal of Theoretical Chemistry","issn_l":"2314-6184","issn":["2314-6184","2356-7686"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310319869","host_organization_name":"Hindawi Publishing Corporation","host_organization_lineage":["https://openalex.org/P4310319869","https://openalex.org/P4310320595"],"host_organization_lineage_names":["Hindawi Publishing Corporation","Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Theoretical Chemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.4043000042438507,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7868381147","display_name":"\u836f\u7269\u6e17\u900f\u6027\u7684\u5206\u5b50\u6a21\u62df","funder_award_id":"21103125","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G8216610574","display_name":null,"funder_award_id":"2011ZX09401-009","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"},{"id":"https://openalex.org/F4320336770","display_name":"National Supercomputing Center of Tianjin","ror":"https://ror.org/05tngxm14"},{"id":"https://openalex.org/F4320337144","display_name":"National Supercomputing Center, Korea Institute of Science and Technology Information","ror":"https://ror.org/00cs28a13"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2162969728.pdf","grobid_xml":"https://content.openalex.org/works/W2162969728.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1500419381","https://openalex.org/W1848098847","https://openalex.org/W1966078827","https://openalex.org/W1981021420","https://openalex.org/W1985359220","https://openalex.org/W2026835783","https://openalex.org/W2034048944","https://openalex.org/W2055265038","https://openalex.org/W2068638436","https://openalex.org/W2086117966","https://openalex.org/W2092511209","https://openalex.org/W2096392545","https://openalex.org/W2103027517","https://openalex.org/W2114367386","https://openalex.org/W2116677194","https://openalex.org/W2123768693","https://openalex.org/W2126980635","https://openalex.org/W2145153842","https://openalex.org/W2165450381","https://openalex.org/W2171268876","https://openalex.org/W3032493906","https://openalex.org/W3082618961"],"related_works":["https://openalex.org/W2914445447","https://openalex.org/W1848098847","https://openalex.org/W1996651651","https://openalex.org/W4417264207","https://openalex.org/W4408093042","https://openalex.org/W4362716715","https://openalex.org/W2182722930","https://openalex.org/W4413474677","https://openalex.org/W2021308700","https://openalex.org/W2026835783"],"abstract_inverted_index":{"The":[0,16,59],"binding":[1],"mode":[2],"of":[3,30,83],"sorafenib":[4,21],"with":[5,25,63,85,109,118],"VEGFR2":[6,31,84,102,110],"was":[7],"studied":[8],"using":[9],"molecular":[10,13,80],"docking":[11,17],"and":[12,28,48,95,111],"dynamics":[14,34,81],"method.":[15],"results":[18,97],"show":[19],"that":[20,37,99],"forms":[22],"hydrogen":[23,39,60,73,116],"bonds":[24,74,117],"Asp1046,":[26],"Cys919,":[27],"Glu885":[29,76],"receptor.":[32],"Molecular":[33],"simulation":[35,57],"suggests":[36],"the":[38,44,55,71,96],"bond":[40,61],"involving":[41,75],"Asp1046":[42],"is":[43,50],"most":[45],"stable":[46],"one,":[47],"it":[49],"almost":[51],"preserved":[52],"during":[53],"all":[54],"MD":[56],"time.":[58],"formed":[62],"Cys919":[64],"occurs":[65,77],"frequently":[66],"after":[67],"6":[68],"ns,":[69],"while":[70],"bifurcated":[72],"occasionally.":[78],"Meantime,":[79],"simulations":[82],"11":[86],"other":[87],"urea-substituted":[88],"aryloxy":[89],"compounds":[90],"have":[91,105],"also":[92],"been":[93],"performed,":[94],"indicate":[98],"a":[100],"potent":[101],"inhibitor":[103],"should":[104],"lower":[106],"interaction":[107],"energy":[108],"create":[112],"at":[113],"least":[114],"2":[115],"VEGFR2.":[119]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}